Dive into October’s Topics
Translational Drug Development (TD2)
The Precision Oncology CRO
Welcome to TD2's Monthly Newsletter! As the months progress, our commitment to being your trusted source for cutting-edge cancer research content remains unwavering. Immerse yourself in a carefully selected assortment of insightful blogs, enlightening scientific posters, informative videos, and introductions to our latest services. Together, let's push the boundaries of oncology research and pave the path to groundbreaking therapies. Stay informed, stay inspired.
ON DEMAND WEBINAR
Checkpoint inhibitors: the gut microbiome’s role in anti-tumor response
This webinar explores how precision oncology can be improved by considering the impact of the gut microbiota on cancer therapy. It discusses the use of mouse models to study immune checkpoint inhibitors, the enhancement of anti-cancer effects through Bifidobacteria supplementation, and the potential benefits of combining an epigenetic immunomodulator with Bifidobacteria.
FEATURED BLOG
Orthotopic vs. Subcutaneous: Unpacking the Strengths and Limitations of Tumor Model Implantation Sites
This post delves into the benefits of orthotopic and subcutaneous tumor implantation methods in cancer research, providing guidance to researchers when choosing between them based on their study objectives. In vivo tumor models play a crucial role in understanding cancer biology and testing therapeutic strategies.
SERVICE SPOTLIGHT
Orthotopic Tumor Models
Researchers are turning to Orthotopic Tumor Models as a game-changing approach in preclinical research. These models offer a closer-to-real-life representation of the tumor microenvironment, enhancing the reliability and translatability of in vivo cancer therapy evaluation.
Translational Oncology Services
Learn more about TD2's Clinical Trial Management and Regulatory Support Services here .